Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; trometamol hydrochloride; sodium hydroxide - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications approved as specified in the letter of 19 april 1993 from dr h. arora are as follows: optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 678 mg/ml (equivalent: iodine, qty 320 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; water for injections; trometamol hydrochloride; sodium hydroxide - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications approved as specified in the letter of 19 april 1993 from dr h. arora are as follows: optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used in intravenous excretory urography. optiray 320 is indicated in children (excluding neonates) for angiography, contrast enhanced computed tomographic imaging of the head and body, and intravenous excretory urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the vardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections; trometamol hydrochloride; trometamol - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.